During the past decade, Hongjun Jin conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hongjun Jin" are "Positron-Emission Tomography" (2 trials), "COVID-19" (1 trials), "Carcinoma, Hepatocellular" (1 trials), "Inflammatory Lesions" (1 trials) and "Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Hongjun Jin" in a lesser frequency.

Most popular intervention types in "Hongjun Jin" are "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "PET/CT dynamic scan" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hongjun Jin" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hongjun Jin". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hongjun Jin, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hongjun Jin, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".